GB201309180D0 - Compounds and Their Uses - Google Patents

Compounds and Their Uses

Info

Publication number
GB201309180D0
GB201309180D0 GBGB1309180.6A GB201309180A GB201309180D0 GB 201309180 D0 GB201309180 D0 GB 201309180D0 GB 201309180 A GB201309180 A GB 201309180A GB 201309180 D0 GB201309180 D0 GB 201309180D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1309180.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1309180.6A priority Critical patent/GB201309180D0/en
Publication of GB201309180D0 publication Critical patent/GB201309180D0/en
Priority to PCT/GB2014/051563 priority patent/WO2014188193A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1309180.6A 2013-05-21 2013-05-21 Compounds and Their Uses Ceased GB201309180D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1309180.6A GB201309180D0 (en) 2013-05-21 2013-05-21 Compounds and Their Uses
PCT/GB2014/051563 WO2014188193A1 (en) 2013-05-21 2014-05-21 Peptidylarginine deiminases (pad) inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1309180.6A GB201309180D0 (en) 2013-05-21 2013-05-21 Compounds and Their Uses

Publications (1)

Publication Number Publication Date
GB201309180D0 true GB201309180D0 (en) 2013-07-03

Family

ID=48747136

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1309180.6A Ceased GB201309180D0 (en) 2013-05-21 2013-05-21 Compounds and Their Uses

Country Status (2)

Country Link
GB (1) GB201309180D0 (en)
WO (1) WO2014188193A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016118476A1 (en) 2015-01-20 2016-07-28 The Children's Medical Center Corporation Anti-net compounds for treating and preventing fibrosis and for facilitating wound healing
GB201516504D0 (en) 2015-09-17 2015-11-04 Astrazeneca Ab Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer
US11453676B2 (en) 2018-02-02 2022-09-27 Forward Therapeutics, Inc. Inhibitors of protein arginine deiminases
WO2021114314A1 (en) * 2019-12-14 2021-06-17 Tongji University Novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666767A (en) * 1970-01-28 1972-05-30 Warner Lambert Co 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
CN1914168A (en) * 2004-02-04 2007-02-14 公立大学法人横浜市立大学 Peptidyl arginine deiminase type IV inhibitor
CA2758829C (en) * 2008-04-18 2018-11-13 The Hospital For Sick Children Method of treating demyelinating disease
US8921595B2 (en) * 2009-10-23 2014-12-30 University Of South Carolina Protein Arginine Deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
EP2395001A1 (en) * 2010-05-21 2011-12-14 Chemilia AB Novel pyrimidine derivatives
DK2688883T3 (en) * 2011-03-24 2016-09-05 Noviga Res Ab pyrimidine
WO2014019092A1 (en) * 2012-08-01 2014-02-06 The Hospital For Sick Children Inhibitors of peptidyl arginine deiminase (pad) enzymes and uses thereof

Also Published As

Publication number Publication date
WO2014188193A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and uses thereof
GB201323008D0 (en) Compounds and uses thereof
GB201317802D0 (en) SmartHaler patent application
GB201312318D0 (en) Novel methods and compounds
GB201300707D0 (en) Compounds and processes
GB201307233D0 (en) Compounds and uses thereof
GB201309180D0 (en) Compounds and Their Uses
GB201320992D0 (en) Complex and uses thereof
AU353576S (en) Stamphousing
HK1223307A1 (en) Novel compounds and uses thereof
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201320161D0 (en) Compounds and their uses
GB201323005D0 (en) Compounds and uses thereof
AU4899P (en) Herbie53 Iresine herbstii
GB201307201D0 (en) New compounds and uses
GB201307202D0 (en) New compounds and uses
AU4953P (en) Flogazora Gazania rigens
AU4977P (en) Harrosy Gaura lindheimeri
GB201301734D0 (en) New compounds and uses
GB201309248D0 (en) Compounds and combinations
GB201313605D0 (en) Novel compounds and their use
GB201301393D0 (en) Kiddibidet and pottibidet
GB201417087D0 (en) No detials

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)